Top cancer drugs in the U.S. based on revenue 2011

Published by Statista Research Department, May 30, 2012
This statistic depicts the top 10 cancer drugs in the United States in 2011, based on revenue. In that year, Swiss pharmaceutical company Roche generated 2.66 billion U.S. dollars of revenue in the United States.

Top 10 cancer drugs in the U.S. based on revenue in 2011 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2012

Region

United States

Survey time period

2011

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Oncology "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RomaniaSanofiBiotechnology in SpainBiotech drugsPfizer
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.